We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AstraZeneca said that the ETHOS trial of triple-drug therapy c formerly known as PT010, helped patients suffering from chronic obstructive pulmonary disease.